My research interest is to elucidate how aberrant RNA splicing contributes to leukemia chemoresistance and to identify new therapeutic targets.
My interest in leukemia research developed during graduate school in Dr. Zan Huang’s laboratory at Wuhan University, where I investigated signaling pathways governing leukemogenesis. For my postdoctoral training, I worked in Dr. Panagiotis Ntziachristos’s laboratory at Northwestern University, investigating aberrant splicing changes and post-translational regulation in T-cell leukemias and their impact on therapeutic responses. I joined in Dr. Eric Wang lab to continue my research to elucidate the regulation of aberrant splicing in leukemia chemoresistance.
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.